GRAIL, Inc. (GRAL) Stock Forecast

GRAIL, Inc. (NASDAQ:GRAL) Released Earnings Last Week And Analysts Lifted Their Price Target To US$40.50

2d ago, source: Yahoo Finance

NasdaqGS:GRAL 1 Year Share Price vs Fair Value Explore GRAIL's Fair Values from the Community and select yours ...

Grail Inc’s Earnings Call Highlights Growth and Optimism

4d ago, source: None

Grail Inc (($GRAL)) has held its Q2 earnings call. Read on for the main highlights of the call. Grail Inc’s recent earnings call conveyed a ...

Grail Inc’s Galleri Test Faces Uncertainty Amid Regulatory Challenges and Rising Competition

3d ago, source: None

Grail Inc (GRAL) has disclosed a new risk, in the Regulation category. Grail Inc faces a potential business risk due to the uncertain regulatory ...

GRAIL Inc (GRAL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

5d ago, source: Yahoo Finance

GRAIL Inc (GRAL) reports an 11% revenue increase and over 45,000 Galleri tests sold, while navigating challenges in reimbursement and FDA approval.

Cancer test maker Grail cuts 350 jobs as part of restructuring program

1y ago, source: Reuters

Grail Inc said on Tuesday it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test Galleri, sending its shares up more than 11 ...

GRAIL, Inc.: GRAIL Reports Second Quarter 2025 Financial Results

5d ago, source: FinanzNachrichten.de

Q2 U.S. Galleri Revenue Grew 21% Year-Over-Year to $34.2 Million Q2 Galleri Tests Sold Grew 29% Year-Over-Year to More Than 45,000 Detailed Results From First 25,000 ...

GRAIL Inc. (GRAL) Q2 2024 Earnings Call Transcript

1y ago, source: Seeking Alpha

GRAIL Inc. (NASDAQ: GRAL) Q2 2024 Results Conference Call August 13, 2024 4:30 PM ET Company Participants Bob Ragusa - CEO & Director Aaron Freidin - Chief Financial Officer Joshua Ofman - President ...

GRAIL to Begin Trading on the Nasdaq Stock Exchange

1y ago, source: Business Wire

GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC) will be listed and commence regular-way trading on the Nasdaq as of tomorrow, June 25, 2024.

34,992 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by Stifel Financial ...

3mon ago, source: ETF Daily News

Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. Grail (NASDAQ:GRAL – Get Free Report) last announced its earnings results on Thursday, February 20th.

Grail lays off 350, pauses hiring with restructuring - Charlotte ...

1y ago, source: The Business Journals

Grail in 2020 announced plans for a large facility in RTP backed by state incentives worth up to $5.2 million over 12 years. The biotech is leasing about 200,000 square feet in Park Point off ...

GRAIL And Athenahealth Partner To Streamline Galleri Multi ... - Nasdaq

3mon ago, source: Nasdaq

(RTTNews) - GRAIL, Inc. (GRAL) has announced a partnership with athenahealth to integrate the ordering of its Galleri multi-cancer early detection or MCED test into athena Coordinator Core, a care ...

Grail shares fall as revenue misses estimates despite narrower loss

5d ago, source: Investing.com

Investing.com -- GRAIL, Inc. (NASDAQ: GRAL ), a healthcare company focused on early cancer detection, saw its shares fall 3.3% after reporting second quarter 2025 revenue that missed analyst ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Aclarion, Inc.	ACON	Predict	2.93	-0.03	1.17
Aclarion, Inc.	ACONW	Predict	0.45	None	0.18
Advanced Biomed Inc.	ADVB	Predict	9.54	None	2.31
AMERICAN SHARED HOSPITAL SERVICES	AMS	Predict	16.38	5.20	0.66
BIODESIX INC	BDSX	Predict	58.05	-3.00	51.01
BioNexus Gene Lab Corp	BGLC	Predict	76.36	None	9.83
Burning Rock Biotech Ltd	BNR	Predict	0.00	None	0.00
Caris Life Sciences, Inc.	CAI	Predict	10259.80	7.55	22.65
CareDx, Inc.	CDNA	Predict	648.61	12.55	1.98
Celcuity Inc.	CELC	Predict	2245.60	-4.47	50.60
CASTLE BIOSCIENCES INC	CSTL	Predict	582.23	-2110.50	1.28
QUEST DIAGNOSTICS INC	DGX	Predict	20305.54	21.37	2.81
EXACT SCIENCES CORP	EXAS	Predict	8628.46	-343.62	3.49
Fulgent Genetics, Inc.	FLGT	Predict	649.52	516.76	0.58
Fortrea Holdings Inc.	FTRE	Predict	730.03	-6.75	1.24
Guardant Health, Inc.	GH	Predict	7329.26	-8.86	-22.95
GRAIL, Inc.	GRAL	Predict	1171.55	None	0.51
LABCORP HOLDINGS INC.	LH	Predict	22783.78	29.84	2.69
Natera, Inc.	NTRA	Predict	22294.13	-74.23	17.89
PSYCHEMEDICS CORP	PMD	Predict	11.79	-5.67	2.16
PSYCHEMEDICS CORP	PMDI	Predict	13.99	None	2.73
Personalis, Inc.	PSNL	Predict	407.79	-2.25	2.14
RadNet, Inc.	RDNT	Predict	6431.66	462.82	6.90
Renalytix plc	RENXF	Predict	9.96	None	None
Renalytix plc	RNLXY	Predict	23.23	None	None
SERA PROGNOSTICS, INC.	SERA	Predict	102.46	-8.99	1.16
VERACYTE, INC.	VCYT	Predict	2414.73	91.69	1.98
EXAGEN INC.	XGN	Predict	208.77	-5.36	9.93